The Novavax jab is the primary to indicate in trials that it’s efficient in opposition to the UK variant of the virus.
Covid-19: Novavax vaccine reveals 89% efficacy in UK trials
The Novavax jab is the primary to indicate in trials that it’s efficient in opposition to the UK variant of the virus.
